New UTI antibiotic shows promise in early trial
NCT ID NCT05138822
First seen Mar 30, 2026 · Last updated May 23, 2026 · Updated 5 times
Summary
This early-stage study tested a new oral antibiotic, GSK3882347, in 140 women with uncomplicated urinary tract infections (UTIs). The goal was to see if the drug could safely clear the infection compared to a standard antibiotic. Results help determine if further testing is warranted.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URINARY TRACT INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
GSK Investigational Site
Anniston, Alabama, 36207, United States
-
GSK Investigational Site
Lomita, California, 90717, United States
-
GSK Investigational Site
Modesto, California, 95350-5365, United States
-
GSK Investigational Site
Doral, Florida, 33166, United States
-
GSK Investigational Site
Miami, Florida, 33186, United States
-
GSK Investigational Site
Miami Lakes, Florida, 33016-1507, United States
-
GSK Investigational Site
Palmetto Bay, Florida, 33157, United States
-
GSK Investigational Site
Sweetwater, Florida, 33172, United States
-
GSK Investigational Site
Chicago, Illinois, 60643, United States
-
GSK Investigational Site
The Bronx, New York, 10456, United States
-
GSK Investigational Site
Smithfield, Pennsylvania, 15478, United States
-
GSK Investigational Site
Austin, Texas, 78705, United States
-
GSK Investigational Site
Dallas, Texas, 75230, United States
-
GSK Investigational Site
Houston, Texas, 77061, United States
-
GSK Investigational Site
Missouri City, Texas, 77459, United States
Conditions
Explore the condition pages connected to this study.